1. Home
  2. FATE vs STRS Comparison

FATE vs STRS Comparison

Compare FATE & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • STRS
  • Stock Information
  • Founded
  • FATE 2007
  • STRS 1992
  • Country
  • FATE United States
  • STRS United States
  • Employees
  • FATE N/A
  • STRS N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • STRS Homebuilding
  • Sector
  • FATE Health Care
  • STRS Real Estate
  • Exchange
  • FATE Nasdaq
  • STRS Nasdaq
  • Market Cap
  • FATE 133.0M
  • STRS 133.9M
  • IPO Year
  • FATE 2013
  • STRS N/A
  • Fundamental
  • Price
  • FATE $1.21
  • STRS $18.15
  • Analyst Decision
  • FATE Hold
  • STRS
  • Analyst Count
  • FATE 8
  • STRS 0
  • Target Price
  • FATE $4.14
  • STRS N/A
  • AVG Volume (30 Days)
  • FATE 1.8M
  • STRS 7.2K
  • Earning Date
  • FATE 05-13-2025
  • STRS 05-15-2025
  • Dividend Yield
  • FATE N/A
  • STRS N/A
  • EPS Growth
  • FATE N/A
  • STRS N/A
  • EPS
  • FATE N/A
  • STRS N/A
  • Revenue
  • FATE $13,335,000.00
  • STRS $32,719,000.00
  • Revenue This Year
  • FATE N/A
  • STRS N/A
  • Revenue Next Year
  • FATE N/A
  • STRS N/A
  • P/E Ratio
  • FATE N/A
  • STRS N/A
  • Revenue Growth
  • FATE 105.85
  • STRS N/A
  • 52 Week Low
  • FATE $0.66
  • STRS $15.10
  • 52 Week High
  • FATE $5.92
  • STRS $30.66
  • Technical
  • Relative Strength Index (RSI)
  • FATE 53.44
  • STRS 48.06
  • Support Level
  • FATE $1.12
  • STRS $17.00
  • Resistance Level
  • FATE $1.38
  • STRS $21.23
  • Average True Range (ATR)
  • FATE 0.12
  • STRS 1.16
  • MACD
  • FATE 0.01
  • STRS -0.19
  • Stochastic Oscillator
  • FATE 62.22
  • STRS 27.19

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

Share on Social Networks: